Xencor | XNCR - Trade Debtors


Xencor reported $29.3M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
J&J USD 17.61B 235M Sep/2025
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025